These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


228 related items for PubMed ID: 22914444

  • 1. Urinary free (unconjugated) metadrenalines in different hereditary forms of catecholamine-secreting phaeochromocytoma/paraganglioma.
    Davidson DF, Bradshaw N, Perry CG, Lindsay R, Freel EM.
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):486-90. PubMed ID: 22914444
    [Abstract] [Full Text] [Related]

  • 2. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A, Rao JU, Lenders JW, Pellegata NS, Kusters B, Piscaer I, Hermus AR, Plantinga TS, Langenhuijsen JF, Vriens D, Janssen MJ, Gotthardt M, Timmers HJ.
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [Abstract] [Full Text] [Related]

  • 3. Phaeochromocytoma with normal urinary catecholamines: the potential value of urinary free metadrenalines.
    Davidson DF.
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):557-66. PubMed ID: 12564837
    [Abstract] [Full Text] [Related]

  • 4. Simple, rapid, and cost-effective microextraction by the packed sorbent method for quantifying of urinary free catecholamines and metanephrines using liquid chromatography-tandem mass spectrometry and its application in clinical analysis.
    Xiong X, Zhang Y.
    Anal Bioanal Chem; 2020 May; 412(12):2763-2775. PubMed ID: 32130439
    [Abstract] [Full Text] [Related]

  • 5. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
    Peitzsch M, Kaden D, Pamporaki C, Langton K, Constantinescu G, Conrad C, Fliedner S, Sinnott RO, Prejbisz A, Därr R, Lenders JWM, Bursztyn M, Eisenhofer G.
    Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
    [Abstract] [Full Text] [Related]

  • 6. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
    Martínez-Morillo E, Valdés Gallego N, Eguia Ángeles E, Fernández Fernández JC, Prieto García B, Álvarez FV.
    Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
    [Abstract] [Full Text] [Related]

  • 7. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
    van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, Sleddens HF, Derkx P, Rivière J, Dannenberg H, Petri BJ, Komminoth P, Pacak K, Hop WC, Pollard PJ, Mannelli M, Bayley JP, Perren A, Niemann S, Verhofstad AA, de Bruïne AP, Maher ER, Tissier F, Méatchi T, Badoual C, Bertherat J, Amar L, Alataki D, Van Marck E, Ferrau F, François J, de Herder WW, Peeters MP, van Linge A, Lenders JW, Gimenez-Roqueplo AP, de Krijger RR, Dinjens WN.
    Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
    [Abstract] [Full Text] [Related]

  • 8. Age-related medical decision limits for urinary free (unconjugated) metadrenalines, catecholamines and metabolites in random urine specimens from children.
    Davidson DF, Hammond PJ, Murphy D, Carachi R.
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):358-66. PubMed ID: 21670092
    [Abstract] [Full Text] [Related]

  • 9. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.
    Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K.
    Clin Chem; 2011 Mar; 57(3):411-20. PubMed ID: 21262951
    [Abstract] [Full Text] [Related]

  • 10. Consideration of the degree of increase in urine metadrenalines provides superior specificity in the diagnosis of phaeochromocytoma than additional urine catecholamine measurement.
    Scargill JJ, Reed P, Kane J.
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):73-5. PubMed ID: 23417444
    [Abstract] [Full Text] [Related]

  • 11. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
    Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, Mannelli M, Friberg P, Grebe SK, Timmers HJ, Bornstein SR, Lenders JW.
    Endocr Relat Cancer; 2011 Feb; 18(1):97-111. PubMed ID: 21051559
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
    Goupil R, Fountoulakis S, Gordon RD, Stowasser M.
    J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433
    [Abstract] [Full Text] [Related]

  • 17. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma.
    Dong Y, Huang Y, Fan C, Wang L, Zhang R, Li W, Guo Z, Wang D, Zheng Z.
    Cell Death Dis; 2021 May 04; 12(5):444. PubMed ID: 33947839
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH, Seong MW, Lee KE, Choi HJ, Ku EJ, Bae JH, Park SS, Choi SH, Kim SW, Shin C, Kim SY.
    Clin Genet; 2014 Nov 04; 86(5):482-6. PubMed ID: 24134185
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.